Salute e Benessere

Precision Medicine Market Witnessing Rapid Expansion, Projected to reach US$…

Precision Medicine is "personalized medicine," which uses information from the patient's genes to diagnose, prevent, and treat disease. Precision medicines are more effective and help reduce the cost, time, and failure rate of pharmaceutical clinical trials, which will likely propel market growth. Precision Medicine is "personalized medicine," which uses information from the patient's genes to diagnose, prevent, and treat disease. Precision medicines are more effective and…
PR Newswire
23/05/2023

Pharmacy Automation Devices Market Worth $11.6 Billion by 2030: Grand View…

Read 161 page full market research report, "Pharmacy Automation Devices Market Size, Share & Trends Analysis Report By Product (Medication Dispensing Systems, Automated Medication Compounding Systems), By End-use (Outpatient Pharmacies), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 161 page full market research report, " Pharmacy Automation Devices Market Size, Share & Trends Analysis Report By Product (Medication Dispensing…
PR Newswire
23/05/2023

Hydrogel Dressing Market Valued at US$ 1,406.2 Million with Impressive CAGR…

Hydrogel Dressings are used in treating burns and ulcers, remove scabs, facilitate autolysis and also used in cleansing wound. Hydrogel dressing pad, CoolMgic, AquaSite, AquaDerm, Elasto-Gel, Avogel are some examples of Hydrogel Dressing which are made from natural or synthetic polymers. Hydrogel Dressings are used in treating burns and ulcers, remove scabs, facilitate autolysis and also used in cleansing wound. Hydrogel dressing pad, CoolMgic, AquaSite, AquaDerm, Elasto-Gel, Avogel are...
PR Newswire
23/05/2023

Advanced Wound Care Market to Reach $10.75 Billion by 2030: Grand View Research…

Read full market research report, "Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use (Hospitals, Home Healthcare), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report, " Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute…
PR Newswire
23/05/2023

Atherosclerosis Drugs Market to Reach $27.7 Billion, Globally, by 2032 at 3.0%…

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/13554 Download Sample Report: https://www.alliedmarketresearch.com/request-sample/13554 Prime determinants of growth Surge in the obesity in the populace, increase in government initiatives to promote healthy lifestyle and development of new treatments for atherosclerosis drive the growth of the global atherosclerosis drugs market. However, the side effects of atherosclerosis drugs restricts the market...
PR Newswire
23/05/2023

Zadar based Dentex is a new member of Adria Dental Group

Dentex is the market leader in the area of Zadar and northern Dalmatia, it employs 42 people and has 13 modernly equipped practices with its own dental laboratory. Dentex is the market leader in the area of Zadar and northern Dalmatia, it employs 42 people and has 13 modernly equipped practices with its own dental laboratory. "We are glad that Adria Dental Group recognized Dentex as a partner that follows the Group's high standards and will further strengthen its position on the market…
PR Newswire
23/05/2023

Scarlet Therapeutics Announces Seed Financing to Advance Development of…

Scarlet was founded by world renowned blood scientists Professor Ash Toye and Professor Jan Frayne, at the University of Bristol, UK, following their decades of research in this field. This includes their work on the ground-breaking RESTORE studyi run by NHS Blood and Transplant, with the Universities of Bristol and Cambridge and other partners, which is investigating transfusion of lab-grown blood into patients. Chief Executive Officer, Alistair Irvine, is a scientist and experienced biotech…
PR Newswire
23/05/2023

Engimmune Therapeutics Announces the Appointment of Dr Annalisa D'Andrea to its…

Dr. D'Andrea has over 25 years of experience in the life-science industry including immunology research, drug discovery and development, and strategic leadership in biotechnology and pharmaceutical companies. She is a Venture Partner at Longwood Fund and is the former President and Chief Scientific Officer of ImmuneID. Prior to ImmuneID she was the Chief Scientific Officer of Kiniksa Pharmaceuticals and was previously Vice President and Global Head of Discovery for Immunology and Inflammation at…
PR Newswire
23/05/2023

KCI, a subsidiary of Samyang Group, has been awarded a 'Gold Medal' in EcoVadis'…

KCI places utmost priority on corporate ethics and proactiveness to climate change initiatives across all its divisions and operational activities. The company obtained the 'RSPO (Roundtable on Sustainable Palm Oil)' certification in 2016, a consultative body for sustainable palm oil production. In 2019, KCI received ISO14001 (Environmental Management) and ISO45001 (OH&S Management) certifications from the International Organization for Standardization. Since 2021, KCI has been publishing…
PR Newswire
23/05/2023

Immunovia Publishes Interim Report for January-March 2023

Significant events after the period Significant events after the period CEO's comments Our mission is simple: We want to save lives by detecting pancreatic cancer earlier. With the IMMray™ PanCan-d test, we can dramatically improve patient survival by identifying pancreatic cancer early when it can still be treated effectively. I am honored and energized to lead Immunovia as the global CEO to achieve our mission. In my first year with Immunovia, as head of U.S. operations, I have...
PR Newswire
23/05/2023

Ariana Grande's r.e.m. beauty Announces Strategic Investment with Sandbridge…

r.e.m. beauty is available on rembeauty.com and currently distributed exclusively at ULTA Beauty in the United States, Sephora across Europe, and Selfridges in the UK. The brand will continue to focus on its core markets, with further expansion plans to be announced. r.e.m. beauty is available onrembeauty.com and currently distributed exclusively at ULTA Beauty inthe United States, Sephora acrossEurope, and Selfridges in the UK. The brand will continue to focus on its core markets,...
PR Newswire
23/05/2023

Food and Drug Administration (FDA) and Clarivate Extend Material Transfer…

The success of clinical research can be jeopardized by unexpected safety issues. It is critical to identify potential safety liabilities as early as possible in the drug research and development (R&D) process. A translational approach to drug safety data can reduce patient burden and support increased success by harmonizing preclinical and clinical data. The success of clinical research can be jeopardized by unexpected safety issues. It is critical to identify potential safety liabilities…
PR Newswire
23/05/2023

Nordic Consulting strengthens team in UK and Ireland to support digitally…

With over 20 years' experience working with providers on digitally enabled transformation programmes, including the largest electronic patient record (EPR) implementations in the NHS and Northern Ireland, Lattimer will be leading Nordic's NHS services and solutions. With over 20 years' experience working with providers on digitally enabled transformation programmes, including the largest electronic patient record (EPR) implementations in the NHS andNorthern Ireland, Lattimer will be leading...
PR Newswire
23/05/2023

PRODUCTLIFE GROUP ACQUIRES CILATUS AND EXPANDS EXPERTISE ON COMPLEX PRODUCTS…

Following a successful career in the US (Bayer, IDEC; Biogen, Genentech) and in Europe (Bayer, Elan Pharmaceutical, Prothena), Johannes Roebers, PhD founded Cilatus BioPharma Consulting in 2014. Cilatus specializes in managing CMC development, GMP Manufacturing, CDMO/CMO Search and Management, Regulatory Affairs and Quality Assurance for large and small molecules of any dosage form as well as Advanced Therapy Medicinal Products. In 2017, Johannes Roebers launched Cilatus Manufacturing Services…
PR Newswire
23/05/2023

Kindred Group utilises authorisation to repurchase own shares

Share repurchases can be made during the period 23 May 2023 and 22 June 2023 and are to be made on Nasdaq Stockholm in accordance with the Nasdaq Nordic Main Market Rulebook for Issuers of Shares, Maltese Companies Act and EU Market Abuse Regulation No. 596/2014 ("MAR"). Share repurchases are to be made at a price per share within the recorded interval, i.e. the interval between the highest buying price and the lowest selling price. Payment for the shares shall be made in cash…
PR Newswire
23/05/2023

OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History

The Company has always believed in the importance of home blood pressure monitoring, even when blood pressure readings could only be obtained at medical facilities. In 1991, the Company launched the world's first automated blood pressure monitor with fuzzy logic technology (*) for greater accuracy and ease of use than manual monitors. In parallel with the advancement of blood pressure monitors, the Company worked continuously to improve and developed the pre-formed cuff that the user can wrap…
PR Newswire
23/05/2023

Junshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab…

According to GLOBOCAN 2020, breast cancer exhibited the highest incidence rates worldwide, with 2.26 million new cases and 0.68 million deaths in 2020. In China, 0.42 million new cases and 0.12 million deaths due to breast cancer were reported in 2020, accounting for 18.4% and 17.1% of global cases, respectively. Amongst these breast cancer cases, approximately 10% to 15% were classified as TNBC. TNBC is a more aggressive type of cancer with a higher risk of recurrence and a poor prognosis...
Nasdaq GlobeNewswire
23/05/2023

Salmon Evolution ASA: Results for the first quarter 2023

Subsequent events Subsequent events The increase in biomass production continued in the first quarter with the Group having a net biomass production of around 740 tonnes and all-time high biomass production of around 320 tonnes in March alone. As per31 March 2023the Company had a total standing biomass of almost 1,500 tonnes. Phase 1 of Indre Harøy was finalized inApril 2023. With all the 12 tanks completed, this will allow for a streamlining of the...
PR Newswire
23/05/2023

Largest Published Real-World Wound Imaging Study Reports MolecuLight® led to…

Management of wound bacterial loads, including biofilm, is paramount to the prevention of infection and its severe and costly complications. During a patient exam, clinicians rely on various tools to guide their treatment decisions; however, some of these tools can be subjective. To address this issue, fluorescence imaging with MolecuLight provides a valuable, objective tool for wound assessment at the bedside, filling a significant gap in current clinical practice. Management of wound...
PR Newswire
23/05/2023

NMD Pharma initiates Phase I safety, tolerability and pharmacokinetics study of…

NMD Pharma initiates Phase I safety , tolerability and pharmacokinetics studyof NMD1343 NMD1343 is a novel small molecule inhibitor of the muscle-specific chloride ion channel, the ClC-1 ion channel , and NMD Pharma's second clinical development candidateAarhus, Denmark, 23 May2023– NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular disorders, today announces that the...
Nasdaq GlobeNewswire
23/05/2023

UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials

"The partnership between UCB and Veeva presents a significant opportunity to drive progress in clinical study execution," said Iris Loew-Friedrich, executive vice president and chief medical officer at UCB. "By delivering digital clinical trials, we reduce the burden on participants and sites, improve trial accessibility, and ensure patients are at the heart of everything we do." "The partnership between UCB and Veeva presents a significant opportunity to drive progress…
PR Newswire
23/05/2023

Galapagos demonstrates commitment to immunology with new data in rheumatoid…

9 poster presentations and 3 abstracts publications reinforce Galapagos' commitment to immunology and the rheumatoid arthritis (RA) patient and healthcare professional communityNew analyses will be presented from long-term extension studies providing insights into filgotinib's effectiveness and safetyInterim baseline characteristics, effectiveness and safety outcomes will be published online from the real-world FILOSOPHY study in RA patients Mechelen , Belgium; 22 May...
Nasdaq GlobeNewswire
22/05/2023

Oxurion Issues EUR 2.0 million in Bonds for Tranche 2 of the Funding Program…

Leuven, BELGIUM, Boston, MA, US –May 22 , 2023 – 7 pm CET– Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 2 of funding under the Subscription Agreement with Atlas Special Opportunities LLC (" Atlas ”). On May 22, 2023, the Company issued 80 convertible bonds to...
Nasdaq GlobeNewswire
22/05/2023

Cold Chain Products Market worth $711 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159802939 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159802939 Browse in-depth TOC on "Cold Chain Products Market" 120 - Tables 50 - Figures 200 - Pages Cold Chain Products Market Scope: In this report, the Cold Chain Products Market for Plasma Fractionation is segmented based on type, end user, and region. "Temperature...
PR Newswire
22/05/2023
Altri  Comunicati